{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:10:45Z","timestamp":1792084245314,"version":"4.4.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100015098","name":"Seoul National University Seoul Metropolitan Government Boramae Medical Center","doi-asserted-by":"publisher","award":["04-2022-0014"],"award-info":[{"award-number":["04-2022-0014"]}],"id":[{"id":"10.13039\/501100015098","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.jns.2023.120744","type":"journal-article","created":{"date-parts":[[2023,7,28]],"date-time":"2023-07-28T03:47:06Z","timestamp":1690516026000},"page":"120744","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Plasma neurofilament light-chain and phosphorylated tau as biomarkers of disease severity in Huntington's disease: Korean cohort data"],"prefix":"10.1016","volume":"452","author":[{"given":"Yun Su","family":"Hwang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eungseok","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manho","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chan Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun Sook","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun Ju","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Hee","family":"Sung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won Tae","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Hwan","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Hyeok","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Joon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee Jin","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beomseok","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung Ah.","family":"Woo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seong Beom","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyum-Yil","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jangsup","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaewon","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Eun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jee-Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2023.120744_bb0005","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.parkreldis.2021.04.017","article-title":"Plasma neurofilament light in Huntington\u2019s disease: a marker for disease onset, but not symptom progression","volume":"87","author":"Parkin","year":"2021","journal-title":"Parkinsonism Relat. Disord."},{"issue":"5","key":"10.1016\/j.jns.2023.120744_bb0010","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1172\/JCI80743","article-title":"Quantification of mutant huntingtin protein in cerebrospinal fluid from Huntington\u2019s disease patients","volume":"125","author":"Wild","year":"2015","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.jns.2023.120744_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/JHD-160196","article-title":"Cerebrospinal fluid biomarkers for Huntington\u2019s disease","volume":"5","author":"Byrne","year":"2016","journal-title":"J. Huntingtons Dis."},{"issue":"Pt 7","key":"10.1016\/j.jns.2023.120744_bb0020","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1093\/brain\/awv107","article-title":"The role of tau in the pathological process and clinical expression of Huntington\u2019s disease","volume":"138","author":"Vuono","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.jns.2023.120744_bb0025","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.parkreldis.2021.03.008","article-title":"Cortical microstructural correlates of plasma neurofilament light chain in Huntington\u2019s disease","volume":"85","author":"Sampedro","year":"2021","journal-title":"Parkinsonism Relat. Disord."},{"issue":"8","key":"10.1016\/j.jns.2023.120744_bb0030","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S1474-4422(17)30124-2","article-title":"Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysis","volume":"16","author":"Byrne","year":"2017","journal-title":"Lancet Neurol."},{"issue":"574","key":"10.1016\/j.jns.2023.120744_bb0035","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abc2888","article-title":"Mutant huntingtin and neurofilament light have distinct longitudinal dynamics in Huntington\u2019s disease","volume":"12","author":"Rodrigues","year":"2020","journal-title":"Sci. Transl. Med."},{"issue":"7","key":"10.1016\/j.jns.2023.120744_bb0040","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1038\/s41374-018-0166-9","article-title":"Spectrum of tau pathologies in Huntington\u2019s disease","volume":"99","author":"Baskota","year":"2019","journal-title":"Lab. Investig."},{"key":"10.1016\/j.jns.2023.120744_bb0045","doi-asserted-by":"crossref","first-page":"574","DOI":"10.3389\/fncel.2019.00574","article-title":"Altered levels and isoforms of tau and nuclear membrane invaginations in Huntington\u2019s disease","volume":"13","author":"Fernandez-Nogales","year":"2019","journal-title":"Front. Cell. Neurosci."},{"issue":"Pt 4","key":"10.1016\/j.jns.2023.120744_bb0050","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1093\/brain\/aww021","article-title":"Is Huntington\u2019s disease a tauopathy?","volume":"139","author":"Gratuze","year":"2016","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.jns.2023.120744_bb0055","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/jnc.13719","article-title":"Cerebrospinal fluid total tau concentration predicts clinical phenotype in Huntington\u2019s disease","volume":"139","author":"Rodrigues","year":"2016","journal-title":"J. Neurochem."},{"issue":"11","key":"10.1016\/j.jns.2023.120744_bb0060","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1002\/mds.26011","article-title":"Diagnostic criteria for Huntington\u2019s disease based on natural history","volume":"29","author":"Reilmann","year":"2014","journal-title":"Mov. Disord."},{"issue":"13","key":"10.1016\/j.jns.2023.120744_bb0065","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1002\/mds.23181","article-title":"A comparison of two brief screening measures of cognitive impairment in Huntington\u2019s disease","volume":"25","author":"Mickes","year":"2010","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.jns.2023.120744_bb0070","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3233\/JHD-190350","article-title":"Cognitive screening tests in Huntington gene mutation carriers: examining the validity of the Mini-mental state examination and the Montreal cognitive assessment","volume":"9","author":"Ringkobing","year":"2020","journal-title":"J. Huntingtons Dis."},{"issue":"12","key":"10.1016\/j.jns.2023.120744_bb0075","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1002\/mds.25578","article-title":"Usefulness of the Montreal cognitive assessment (MoCA) in Huntington\u2019s disease","volume":"28","author":"Gluhm","year":"2013","journal-title":"Mov. Disord."},{"issue":"15","key":"10.1016\/j.jns.2023.120744_bb0080","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1002\/mds.23337","article-title":"Challenges assessing clinical endpoints in early Huntington disease","volume":"25","author":"Paulsen","year":"2010","journal-title":"Mov. Disord."},{"issue":"11","key":"10.1016\/j.jns.2023.120744_bb0085","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1093\/brain\/awx255","article-title":"Presence of tau pathology within foetal neural allografts in patients with Huntington's and Parkinson's disease","volume":"140","author":"Cisbani","year":"2017","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.jns.2023.120744_bb0090","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/s41467-020-14612-6","article-title":"Serum neurofilament light levels in normal aging and their association with morphologic brain changes","volume":"11","author":"Khalil","year":"2020","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.jns.2023.120744_bb0095","doi-asserted-by":"crossref","first-page":"4667","DOI":"10.1007\/s12035-020-02035-9","article-title":"Different Clinical contexts of use of blood neurofilament light chain protein in the spectrum of neurodegenerative diseases","volume":"vol. 57","author":"Palermo","year":"2020","journal-title":"Mol. Neurobiol."},{"issue":"8","key":"10.1016\/j.jns.2023.120744_bb0100","doi-asserted-by":"crossref","first-page":"e717","DOI":"10.1212\/WNL.0000000000005005","article-title":"Neurofilament light protein in blood predicts regional atrophy in Huntington disease","volume":"90","author":"Johnson","year":"2018","journal-title":"Neurology"},{"issue":"458","key":"10.1016\/j.jns.2023.120744_bb0105","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aat7108","article-title":"Evaluation of mutant huntingtin and neurofilament proteins as potential markers in Huntington\u2019s disease","volume":"10","author":"Byrne","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jns.2023.120744_bb0110","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3389\/fnagi.2019.00254","article-title":"Role of Neurofilament light chain as a potential biomarker for Alzheimer\u2019s disease: a correlative Meta-analysis","volume":"11","author":"Jin","year":"2019","journal-title":"Front. Aging Neurosci."},{"issue":"3","key":"10.1016\/j.jns.2023.120744_bb0115","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41591-020-0762-2","article-title":"Treatment for frontotemporal lobar degeneration, diagnostic value of plasma phosphorylated tau181 in Alzheimer\u2019s disease and frontotemporal lobar degeneration","volume":"26","author":"Thijssen","year":"2020","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.jns.2023.120744_bb0120","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00401-017-1786-7","article-title":"Co-occurrence of mixed proteinopathies in late-stage Huntington\u2019s disease","volume":"135","author":"St-Amour","year":"2018","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jns.2023.120744_bb0125","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.580732","article-title":"Targeting tau to treat clinical features of Huntington\u2019s disease","volume":"11","author":"Masnata","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jns.2023.120744_bb0130","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3389\/fneur.2013.00083","article-title":"The importance of tau phosphorylation for neurodegenerative diseases","volume":"4","author":"Noble","year":"2013","journal-title":"Front. Neurol."},{"issue":"2","key":"10.1016\/j.jns.2023.120744_bb0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0172762","article-title":"Tau or neurofilament light\u2014which is the more suitable biomarker for Huntington\u2019s disease?","volume":"12","author":"Niemel\u00e4","year":"2017","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.jns.2023.120744_bb0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0193492","article-title":"Cerebrospinal fluid sCD27 levels indicate active T cell-mediated inflammation in premanifest Huntington's disease","volume":"13","author":"Niemel\u00e4","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jns.2023.120744_bb0145","first-page":"483","article-title":"Plasma tau complements CSF tau and P-tau in the diagnosis of Alzheimer's disease","volume":"11","author":"Fossati","year":"2019","journal-title":"Alzheim. Dement. Diagn. Assess. & Disease Monit."},{"issue":"12","key":"10.1016\/j.jns.2023.120744_bb0150","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201911170","article-title":"Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease","volume":"11","author":"Palmqvist","year":"2019","journal-title":"EMBO Mol. Med."},{"issue":"4","key":"10.1016\/j.jns.2023.120744_bb0155","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22041561","article-title":"What, when and how to measure-peripheral biomarkers in therapy of Huntington\u2019s disease","volume":"22","author":"Przybyl","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.jns.2023.120744_bb0160","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1093\/hmg\/ddu421","article-title":"Mutant huntingtin alters tau phosphorylation and subcellular distribution","volume":"24","author":"Blum","year":"2014","journal-title":"Hum. Mol. Genet."},{"issue":"4","key":"10.1016\/j.jns.2023.120744_bb0165","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/j.ymthe.2022.01.020","article-title":"Passive immunization against phosphorylated tau improves features of Huntington\u2019s disease pathology","volume":"30","author":"Alpaugh","year":"2022","journal-title":"Mol. Ther."},{"issue":"8","key":"10.1016\/j.jns.2023.120744_bb0170","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/nm.3617","article-title":"Huntington\u2019s disease is a four-repeat tauopathy with tau nuclear rods","volume":"20","author":"Fern\u00e1ndez-Nogales","year":"2014","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.jns.2023.120744_bb0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/JHD-230569","article-title":"Implications of tau dysregulation in Huntington\u2019s disease and potential for new therapeutics","volume":"12","author":"Mees","year":"2023","journal-title":"J. Huntingtons Dis."},{"issue":"7","key":"10.1016\/j.jns.2023.120744_bb0180","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S1474-4422(22)00120-X","article-title":"Huntington\u2019s disease regulatory science, a biological classification of Huntington\u2019s disease: the integrated staging system","volume":"21","author":"Tabrizi","year":"2022","journal-title":"Lancet Neurol."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X23002058?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X23002058?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T16:02:28Z","timestamp":1758384148000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X23002058"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":36,"alternative-id":["S0022510X23002058"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2023.120744","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasma neurofilament light-chain and phosphorylated tau as biomarkers of disease severity in Huntington's disease: Korean cohort data","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2023.120744","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"120744"}}